Bridgewater Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$424K Sell
4,318
-87
-2% -$6.7K 0.03% 288
2025
Q4
$359K Buy
4,405
+263
+6% +$20.7K 0.02% 329
2025
Q3
$326K Buy
4,142
+217
+6% +$14.9K 0.02% 328
2025
Q2
$235K Buy
3,925
+132
+3% +$8.66K 0.02% 394
2025
Q1
$247K Buy
+3,793
New +$227K 0.02% 352
2023
Q2
Sell
-15,390
Closed -$1.14M 109
2023
Q1
$1.14M Sell
15,390
-256
-2% -$21.5K 0.25% 74
2022
Q4
$1.46M Sell
15,646
-3,623
-19% -$350K 0.35% 59
2022
Q3
$1.84M Buy
19,269
+3,606
+23% +$357K 0.51% 45
2022
Q2
$1.45M Buy
15,663
+97
+0.6% +$9.47K 0.3% 56
2022
Q1
$1.57M Buy
+15,566
New +$1.64M 0.38% 56

Other funds holding CVS

Bridgewater Advisors's CVS Position: Q1 2026 in Review

Bridgewater Advisors reduced its CVS Health (CVS) stake by 2% in Q1 2026, selling an estimated $6.7K and leaving 4,318 shares worth $424K. The position accounts for 0.03% of the portfolio, ranked #288.

Bridgewater Advisors first reported a position in CVS in Q1 2022 and has held it in 10 quarters since. The position peaked at $1.84M in Q3 2022. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Bridgewater Advisors held 4,318 shares of CVS Health worth $424K as of Q1 2026.
  • Bridgewater Advisors sold 87 CVS Health shares in Q1 2026, an estimated $6.7K.
  • CVS Health made up 0.03% of Bridgewater Advisors's portfolio in Q1 2026, its #288 holding.
  • Bridgewater Advisors first reported a position in CVS Health in Q1 2022 and has held it in 10 quarters since.
  • Bridgewater Advisors's CVS Health position peaked at $1.84M in Q3 2022.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Bridgewater Advisors's 13F filing for Q1 2026, filed 14 May 2026.